Swiss Life Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
8,333
+1,275
+18% +$139K 0.01% 650
2026
Q1
$652K Buy
7,058
+1,768
+33% +$178K ﹤0.01% 779
2025
Q4
$540K Buy
5,290
+63
+1% +$5.64K ﹤0.01% 769
2025
Q3
$327K Buy
+5,227
New +$284K ﹤0.01% 871

Other funds holding GH

Swiss Life Asset Management's GH Position: Q2 2026 in Review

Swiss Life Asset Management increased its Guardant Health (GH) stake by 18% in Q2 2026, buying an estimated $139K and bringing the position to 8,333 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #650.

Swiss Life Asset Management first reported a position in GH in Q3 2025 and has held it in 4 quarters since. 425 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Swiss Life Asset Management held 8,333 shares of Guardant Health worth $1.25M as of Q2 2026.
  • Swiss Life Asset Management bought 1,275 Guardant Health shares in Q2 2026, an estimated $139K.
  • Guardant Health made up 0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #650 holding.
  • Swiss Life Asset Management first reported a position in Guardant Health in Q3 2025 and has held it in 4 quarters since.
  • 425 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.